FHI 360, with support from the Gates Foundation and in partnership with the Gates Medical Research Institute, is researching preferences of potential end-users and providers of hypothetical long-acting injectable TB treatment regimens.
FHI 360 is a nonprofit organization that mobilizes research, resources and relationships so that people everywhere can access the opportunities they need to lead full, healthy lives. Our staff of more than 4,000 experts work in over 60 countries around the world.
Our leaders center the expertise and experiences of community partners in everything we do so that together we can build a world where people everywhere have access to what they need to lead full and healthy lives.
FHI 360 is a nonprofit organization that mobilizes research, resources and relationships so that people everywhere can access the opportunities they need to lead full, healthy lives. Our staff of more than 2,200 experts work in over 60 countries around the world. We have spent more than 50 years developing bold solutions to global challenges […]
Putting opportunity within reach FHI 360 has spent more than 50 years developing bold solutions to global challenges and creating measurable results. Who we are FHI 360 is a nonprofit organization that mobilizes research, resources and relationships so that people everywhere can access the opportunities they need to lead full, healthy lives. Learn more about […]
Effective Date: April 19, 2021 Last Updated: June 4, 2024 In this Privacy Notice, we explain how FHI 360 and its subsidiaries FHI Clinical Inc., FHI Partners LLC, FHI Solutions LLC and FHI Ventures Inc. (collectively, “FHI 360,” “Company,” “we,” “our” or “us”) collect, use, store, share and protect your personal information. This Notice applies […]
FHI Ventures
Operating Status: Operating
FHI Ventures: Accelerating social enterprises for impactful business and social returns.